september 05, 2022 0 0 CELEX:62019CA0106: Joined Cases C-106/19 and C-232/19: Judgment of the Court (Grand Chamber) of 14 July 2022 — Italian Republic (C-106/19), Comune di Milano (C-232/19) v Council of the European Union, European Parliament (Action for annulment — Law governing the institutions — Regulation (EU) 2018/1718 — Location of the seat of the European Medicines Agency (EMA) in Amsterdam (Netherlands) — Article 263 TFEU — Admissibility — Interest in bringing proceedings — Locus standi — Direct and individual concern — Decision adopted by the Representatives of the Governments of the Member States in the margins of a Council meeting in order to determine the location of the seat of an EU agency — Absence of binding effects in the EU legal order — Prerogatives of the European Parliament)
avgust 12, 2024 0 0 CELEX:62019CA0144: Case C-144/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – Lupin Ltd v European Commission (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement)
avgust 12, 2024 0 0 CELEX:62019CA0151: Case C-151/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – European Commission v KRKA, tovarna zdravil, d.d. (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Market sharing – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement – Patent licence agreement – Technology assignment and licence agreement)
avgust 12, 2024 0 0 CELEX:62019CA0164: Case C-164/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – Niche Generics Ltd v European Commission (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement)
avgust 12, 2024 0 0 CELEX:62019CA0166: Case C-166/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – Unichem Laboratories Ltd v European Commission (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement)
april 25, 2022 0 0 CELEX:62019CA0167: Joined Cases C-167/19 P and C-171/19 P: Judgment of the Court (Fourth Chamber) of 10 March 2022 — European Commission v Freistaat Bayern and Others (Appeal — State aid — Aid in favour of the German dairy sector — Financing of milk quality tests — Article 108(2) TFUE — Decision to initiate the formal investigation procedure — Regulation (EC) No 659/1999 — Article 6(1) — Obligation for the European Commission to summarise the relevant issues of fact and law in that decision — Scope — Rights of interested parties to be involved in the administrative procedure — Breach of an essential procedural requirement — Consequences for the lawfulness of the final decision)
avgust 12, 2024 0 0 CELEX:62019CA0176: Case C-176/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – European Commission v Servier SAS, Servier Laboratories Ltd, Les Laboratoires Servier, European Federation of Pharmaceutical Industries and Associations (EFPIA) (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Market sharing – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement – Patent licence agreement – Technology assignment and licence agreement – Article 102 TFEU – Relevant market – Abuse of dominant position)
marec 07, 2022 0 0 CELEX:62019CA0177: Joined Cases C-177/19 P to C-179/19 P: Judgment of the Court (Fifth Chamber) of 13 January 2022 — Federal Republic of Germany v Ville de Paris (France), Ville de Bruxelles (Belgium), Ayuntamiento de Madrid (Spain), European Commission (C-177/19 P), Hungary v Ville de Paris (France), Ville de Bruxelles (Belgium), Ayuntamiento de Madrid (Spain), European Commission (C-178/19 P), European Commission v Ville de Paris (France), Ville de Bruxelles (Belgium), Ayuntamiento de Madrid (Spain) (C-179/19 P) (Appeal — Action for annulment — Environment — Type approval of motor vehicles — Regulation (EU) 2016/646 — Emissions from light passenger and commercial vehicles (Euro 6) — Setting of the not-to-exceed (NTE) values for emissions of oxides of nitrogen during the real driving emis
avgust 12, 2024 0 0 CELEX:62019CA0197: Case C-197/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – Mylan Laboratories Ltd, Mylan Inc. v European Commission (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement)
avgust 12, 2024 0 0 CELEX:62019CA0198: Case C-198/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – Teva UK Ltd, Teva Pharmaceuticals Europe BV, Teva Pharmaceutical Industries Ltd v European Commission, European Generic medicines Association AISBL (EGA) (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement)